Abstract
Mycobacterium fortuitum, a rapidly growing atypical mycobacteria, is commonly found in soil and water. This organism is most often known to cause skin, bone, and soft tissue infections associated with local trauma, surgical procedures, and in patients with immunodeficiency. Nosocomial infections associated with a variety of contaminated devices and equipment have also been widely documented. This report presents the first cases of M. fortuitum infection following laparoscopic gastric banding procedures. Both patients had complicated clinical courses necessitating removal of their banding devices and long-term antibiotic therapy.
References
Falkinham JO. Nontuberculous mycobacteria in the environment. Clin Chest Med. 2002;23:529–51.
American Thoracic Society. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial disease. Am J Respir Crit Care Med. 2007;175:367–416.
Herold RC, Lotke PA, MacGregor RR. Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum. Clin Orthop Relat Res. 1987;216:183–7.
Hemmersbach-Miller M, Cardenes-Santana M, Conde-Martel A, et al. Cardiac device infections due to Mycobacterium fortuitum. Can J Infect Dis Med Microbiol. 2005;16:183–4.
Hoy JF, Rolston KV, Hopfer RF, et al. Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters. Am J Med. 1987;83:213–7.
Phillips MS, von Reyn CF. Nosocomial infections due to nontuberculous mycobacteria. Clin Infect Dis. 2001;33:1363–74.
Brown-Elliott BA, Wallace RJ. Clinical and taxonomic status of pathogenic non-pigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002;15:716–46.
Hoffman PC, Fraser DW, Robiesek F, et al. Two outbreaks of sternal wound infections due to organisms of the Mycobacterium fortuitum complex. J Infect Dis. 1981;143:533–42.
Wallace RJ, Steele LC, Labidi A, et al. Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammoplasty despite case clustering in Texas and other southern coastal states. J Infect Dis. 1989;160:281–8.
Swenson JM, Wallace RJ, Silcox VA, et al. Antimicrobial susceptibility testing of 5 subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985;28:807–11.
Patel JB, Leonard D, Pan X, et al. Sequence-based identification of Mycobacterium species using the MicroSeq 50016S rDNA bacterial identification system. J Clin Microbiol. 2000;38:246–51.
Turenne CY, Tshetter L, Wolfe J, et al. Necessity of quality controlled 16S rRNA gene sequence databases: identifying nontuberculous mycobacterial species. J Clin Microbiol. 2001;39:3637–48.
Bueter M, Maroske J, Thalheimer A, et al. Short- and long-term results of laparoscopic gastric banding for morbid obesity. Langenbecks Arch Surg. 2008;393:199–205.
Martin LF, Smits GJ, Greenstein RJ. Treating morbid obesity with laparoscopic adjustable gastric banding. Am J Surg. 2007;194:333–43.
Susmallian S, Ezri T, Elis M, et al. Access-port complications after laparoscopic gastric banding. Obes Surg. 2003;13:128–31.
Abu-Abeid S, Keidar A, Gavert N, et al. The clinical spectrum of band erosion following laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc. 2003;17:861–3.
Conflict of Interest Disclosure
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Callen, E.C., Kessler, T.L. Mycobacterium fortuitum Infections Associated with Laparoscopic Gastric Banding. OBES SURG 21, 404–406 (2011). https://doi.org/10.1007/s11695-010-0123-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-010-0123-1